查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2105006

血管內影像市場規模、佔有率和趨勢分析：按技術、產品、應用、最終用戶和地區分類－全球市場機會分析和產業預測（2026-2036 年）

Intravascular Imaging Market Size, Share & Trends Analysis by Technology (IVUS, OCT, NIRS, Multi-modality), Product (Catheters, Consoles, Software), Application, End User, and Geography - Global Opportunity Analysis and Industry Forecast (2026-2036)
出版日期: | 出版商: Meticulous Research | 英文 280 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

全球血管內影像市場預計在2026年達到13.9億美元，預計到2036年將達到28.5億美元。預測期內的複合年成長率預計為7.5%。本報告透過評估當前市場動態、技術進步、臨床進展、競爭策略以及關鍵技術、產品、應用、終端用戶和地區的未來成長機遇，對全球市場進行了全面分析。

血管內成像技術正在變革介入性心臟病學和血管醫學，它能夠即時可視化血管形態、斑塊特徵、管腔尺寸以及支架部署。與傳統血管造影術不同，血管內影像可提供高解析度截面影像，從而支持經皮冠狀動脈介入治療（PCI）和周邊血管介入治療中病變的精確評估、器械的最佳選擇、支架尺寸的精確確定以及手術流程的最佳化。血管內超音波（IVUS）、光學同調斷層掃描（OCT）、近紅外線光譜（NIRS）和混合成像平台等技術正日益成為現代影像導引心血管手術中不可或缺的關鍵要素。

全球心血管疾病負擔日益加重，冠狀動脈疾病（CAD）和周邊動脈疾病（PAD）盛行率不斷上升，微創手術的日益普及，以及越來越多的臨床證據支持影像引導介入治療，這些都是推動市場成長的主要因素。大量臨床研究表明，與血管攝影介入治療相比，血管內血管造影術引導下的經皮冠狀動脈介入治療（PCI）能夠提高手術精準度，減少心血管不利事件，最佳化支架擴張，並改善患者的長期預後。醫生對精準介入心臟病學的認知不斷提高，臨床指引的最佳化以及精準介入性心臟病學的日益普及，都將繼續加速市場成長。

由於人工智慧 (AI)、機器學習、自動化血管分析、影像處理、混合成像系統、計算生理學、雲端資料管理和導管工程等領域的不斷進步，血管內成像的能力正在顯著提升。現代平台擴大整合了人工智慧驅動的管腔分割、斑塊表徵、自動支架最佳化、鈣化定量和即時手術指導等功能，從而在提高診斷準確性的同時，減少了操作者差異和手術時間。與導管檢查室資訊系統、心血管資訊系統 (CVIS) 和電子健康記錄(EHR) 的整合進一步提高了臨床工作流程的效率。

本報告透過分析當前市場動態、創新、監管環境、競爭格局以及關鍵技術、產品、應用、終端用戶和地區的未來成長機遇，對全球血管內成像市場進行了全面評估。該研究考察了關鍵市場趨勢、保險報銷趨勢、投資活動、醫生採納情況、策略聯盟以及領先企業採取的競爭策略，為醫療設備製造商、醫療服務提供者、心血管專家、投資者以及心血管成像生態系統中的其他相關人員提供了切實可行的見解。

市場動態

由於心血管疾病盛行率不斷上升、複雜冠狀動脈和周邊血管介入手術數量增加、微創治療方法日益普及以及對精準引導心血管手術的日益重視，血管內影像市場正穩步擴張。介入性心臟科醫師擴大利用血管內影像來提高病變評估的準確性、最佳化支架置入、減少手術併發症並改善長期臨床療效。隨著支持影像引導經皮冠狀動脈介入治療（PCI）的證據不斷積累，其在臨床實踐中的應用也日益廣泛。

技術創新仍然是市場成長的主要驅動力。最新的血管內影像系統日益融合了人工智慧、自動影像分析、血管內超音波-光學相干斷層掃描（IVUS-OCT）混合平台、先進的導管插入技術、雲端運算、機器學習和定量影像分析。這些技術能夠實現自動管腔測量、斑塊表徵、鈣化評估、支架黏附分析和手術最佳化，同時減少對臨床醫生的依賴。與導管室系統、心血管資訊系統（CVIS）和醫院資訊系統（HIS）的進一步整合正在提高手術效率和臨床工作流程。

人工智慧驅動的診斷成像和多重模式平台的快速發展進一步加速了市場成長。製造商正陸續推出結合血管內超音波（IVUS）、光學相干斷層掃描（OCT）和近紅外光譜（NIRS）等互補技術的診斷影像系統，因此能夠對血管病變的結構和成分進行全面評估。人工智慧軟體能夠自動測量血管直徑、進行即時影像分析並提供手術決策支持，提高了手術操作的一致性，並促使介入獸醫更多地採用這些技術。

儘管存在巨大的成長機遇，但仍有許多因素阻礙市場滲透。設備和一次性導管的高成本、不同醫療系統報銷政策的差異、醫生技能水平的提升曲線、開發中國家先進導管檢查室的匱乏以及對手術費用的擔憂，仍然是重要的障礙。此外，醫療機構還需要致力於工作流程整合、醫師培訓以及影像方案的標準化，以最大限度地發揮血管內影像技術的臨床優勢。

儘管如此，該市場仍為醫療設備製造商、醫療服務提供者、循環系統和醫療系統提供了巨大的機會。影像導引經皮冠狀動脈介入治療（PCI）的日益普及、周邊血管介入治療的擴展、檢查室現代化改造投資的增加、人工智慧影像分析的日益廣泛應用以及混合成像技術的持續創新，預計將支撐市場的持續成長。醫療設備製造商、醫院、學術機構、循環系統學會和技術開發商之間的策略合作正在加速整個血管內成像生態系統的產品創新、臨床研究、醫生教育和商業化進程。

細分市場分析

本報告按技術、產品、應用、最終用戶和地區對血管內成像市場進行了詳細分析，以幫助相關人員識別高成長細分市場和新興投資機會。

依技術分類，市場分析涵蓋血管內超音波（IVUS）、光學同調斷層掃描（OCT）、近紅外線光譜（NIRS）和多重模式成像。

血管內超音波（IVUS）憑藉其廣泛的臨床應用、豐富的循證醫學證據以及在冠狀動脈和周邊血管介入治療中準確評估血管尺寸、斑塊負荷、管腔大小和支架擴張情況的能力，佔據了最大的市場佔有率。 IVUS正擴大用於最佳化經皮冠狀動脈介入治療（PCI）、提高手術精準度、降低血管再阻塞以及輔助治療複雜冠狀動脈病變。

光學同調斷層掃描（OCT）憑藉其超高解析度成像能力，能夠詳細顯示血管微觀結構、斑塊形態、支架梁黏附情況、組織覆蓋度以及手術結果，預計在預測期內將實現最快成長。醫師對OCT引導下經皮冠狀動脈介入治療（PCI）的偏好日益增強，以及科技的不斷進步，正在加速其市場應用。

近紅外線光譜（NIRS）因其能夠識別富含脂質的斑塊並評估斑塊成分，從而輔助心血管風險評估和治療方案製定，而持續受到關注。此外，隨著臨床醫生越來越希望在一次診療過程中獲得血管結構和成分的全面評估，整合了血管內超音波（IVUS）、光學相干斷層掃描（OCT）和近紅外光譜（NIRS）的多重模式成像平台也預計將迎來顯著成長。

目錄

第1章 市場定義和範圍

第2章：調查方法

第3章執行摘要

  • 基於細分市場的分析
    • 市場分析：按技術分類
    • 按產品成分進行市場分析
    • 市場分析：按應用領域
    • 市場分析：依最終用戶分類
    • 市場分析：按地區分類
  • 競爭分析

第4章 市場洞察

  • 影響市場成長的因素
    • 促進因素
      • 複雜PCI和鈣化病變病例數增加
      • 強力的臨床證據支持影像引導下經皮冠狀動脈介入治療（統計數據：標靶血管失敗率降低 38%）
      • 整合人工智慧驅動的船舶自動化分析工具
    • 抑制因子
      • 高昂的治療費用和報銷金額的差異
      • 對技術學習曲線和流程效率的擔憂。
    • 機會
      • 業務拓展至周邊血管介入周邊動脈疾病（PAD）
      • 部署基於雲端的遠距考試監考和遠端支援
    • 任務
      • 聯網主機中的網路安全和資料隱私管理
      • IVUS 和 OCT 模式之間的競爭
    • 趨勢
      • 向軟體定義的多重模式成像平台遷移
      • 人工智慧驅動的即時流程最佳化技術的興起
  • 波特五力分析
  • 監理情勢
  • 價值鏈分析

第5章 全球血管內影像市場：依技術分類

  • 血管內超音波（IVUS）
    • 旋轉式血管內超音波
    • 固態（相位陣列）血管內超音波
  • 光學同調斷層掃描（OCT）
  • 近紅外線光譜（NIRS）
  • 多重模式影像診斷系統

第6章 全球血管內影像市場：依產品組件分類

  • 成像導管（一次性）
    • 冠狀動脈導管
    • 周邊導管
  • 成像主機和硬體
  • 軟體和人工智慧模組

第7章 全球血管內影像市場：依應用分類

  • 冠狀動脈介入治療
    • 複雜的PCI和CTO
    • 左主幹動脈介入治療
  • 周邊干預
    • 頸動脈影像
    • 髂股骨和膕窩的影像學檢查

第8章 全球血管內影像市場：依最終用戶分類

  • 醫院和心臟導管檢查室
  • 門診手術中心（ASC）
  • 學術研究機構

第9章 全球血管內影像市場：按地區分類

  • 北美洲
    • 美國（統計數據：全球市佔率約 40%）
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本（統計：PCI影像技術普及率超過80%）
    • 中國
    • 印度
    • 澳洲
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東和非洲

第10章 競爭格局

  • 關鍵成長策略
  • 競爭對手儀錶板
  • 供應商市場定位
  • 2025年市佔率分析

第11章：公司簡介

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Royal Philips（Philips Healthcare）
  • Terumo Corporation
  • Infraredx, Inc.（Nipro Corporation）
  • ACIST Medical Systems（Bracco Group）
  • Conavi Medical Inc.
  • Gentuity, LLC
  • Axle International
  • Insight Guided Systems
  • Avinger, Inc.
  • Silicon Valley Medical Instruments
  • Pulse Medical Imaging Technology（Shanghai）Co., Ltd.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • MicroPort Scientific Corporation
  • APT Medical Inc.

第12章附錄

簡介目錄
Product Code: MRHC - 1042016

The global Intravascular Imaging Market is estimated to be valued at USD 1.39 billion in 2026 and is projected to reach USD 2.85 billion by 2036, registering a CAGR of 7.5% during the forecast period. The report provides a comprehensive assessment of the global market by evaluating current industry dynamics, technological advancements, clinical developments, competitive strategies, and future growth opportunities across major technologies, products, applications, end users, and geographic regions.

Intravascular imaging technologies are transforming interventional cardiology and vascular medicine by enabling real-time visualization of vessel morphology, plaque characteristics, lumen dimensions, and stent deployment from within blood vessels. Unlike conventional angiography, intravascular imaging provides high-resolution cross-sectional images that support accurate lesion assessment, optimal device selection, precise stent sizing, and procedural optimization during percutaneous coronary intervention (PCI) and peripheral vascular interventions. Technologies such as intravascular ultrasound (IVUS), optical coherence tomography (OCT), near-infrared spectroscopy (NIRS), and hybrid imaging platforms are increasingly becoming integral components of modern image-guided cardiovascular procedures.

The increasing global burden of cardiovascular diseases, rising prevalence of coronary artery disease (CAD) and peripheral artery disease (PAD), growing adoption of minimally invasive procedures, and expanding clinical evidence supporting imaging-guided interventions are major factors driving market growth. Numerous clinical studies have demonstrated that intravascular imaging-guided PCI improves procedural precision, reduces adverse cardiovascular events, optimizes stent expansion, and enhances long-term patient outcomes compared with angiography-guided interventions. Growing physician awareness, favorable clinical guidelines, and increasing adoption of precision interventional cardiology continue to accelerate market expansion.

Continuous advancements in artificial intelligence (AI), machine learning, automated vessel analysis, image processing, hybrid imaging systems, computational physiology, cloud-based data management, and catheter engineering are significantly enhancing intravascular imaging capabilities. Modern platforms increasingly integrate AI-powered lumen segmentation, plaque characterization, automated stent optimization, calcification quantification, and real-time procedural guidance to improve diagnostic accuracy while reducing operator variability and procedure time. Integration with catheterization laboratory information systems, cardiovascular information systems (CVIS), and electronic health records (EHRs) further strengthens clinical workflow efficiency.

This report provides a comprehensive assessment of the global intravascular imaging market by analyzing current industry dynamics, technological innovations, regulatory developments, competitive landscape, and future growth opportunities across major technologies, products, applications, end users, and geographic regions. The study evaluates key market trends, reimbursement developments, investment activities, physician adoption patterns, strategic collaborations, and competitive strategies adopted by leading industry participants to provide actionable insights for medical device manufacturers, healthcare providers, cardiovascular specialists, investors, and other stakeholders operating within the cardiovascular imaging ecosystem.

Market Dynamics

The intravascular imaging market is expanding steadily due to the increasing prevalence of cardiovascular diseases, growing volume of complex coronary and peripheral interventions, rising adoption of minimally invasive treatment approaches, and increasing emphasis on precision-guided cardiovascular procedures. Interventional cardiologists are increasingly utilizing intravascular imaging to improve lesion assessment, optimize stent deployment, reduce procedural complications, and improve long-term clinical outcomes. The growing body of evidence supporting imaging-guided PCI continues to encourage wider clinical adoption.

Technological innovation remains a major factor shaping market growth. Modern intravascular imaging systems increasingly integrate artificial intelligence, automated image interpretation, hybrid IVUS-OCT platforms, advanced catheter technologies, cloud computing, machine learning, and quantitative image analysis. These technologies enable automated lumen measurements, plaque characterization, calcification assessment, stent apposition analysis, and procedural optimization while reducing operator dependence. Increasing integration with catheterization laboratory systems, cardiovascular information systems (CVIS), and hospital information systems (HIS) further improves procedural efficiency and clinical workflow.

The rapid evolution of AI-assisted imaging and multi-modality platforms is further accelerating market development. Manufacturers are increasingly introducing imaging systems that combine complementary technologies such as IVUS, OCT, and NIRS to provide comprehensive structural and compositional assessment of vascular lesions. AI-powered software enables automated vessel sizing, real-time image analysis, and procedural decision support, improving procedural consistency and expanding adoption among interventional physicians.

Despite strong growth opportunities, several factors continue to influence market adoption. High equipment and disposable catheter costs, reimbursement variability across healthcare systems, physician learning curves, limited access to advanced catheterization laboratories in developing countries, and procedural cost considerations remain important barriers. Healthcare providers must also address workflow integration, physician training, and standardization of imaging protocols to maximize the clinical benefits of intravascular imaging technologies.

The market nevertheless presents substantial opportunities for medical device manufacturers, healthcare providers, cardiovascular specialists, and healthcare systems. Increasing adoption of imaging-guided PCI, expanding peripheral vascular interventions, growing investments in catheterization laboratory modernization, rising implementation of AI-assisted image analysis, and continuous innovation in hybrid imaging technologies are expected to support sustained market growth. Strategic collaborations among medical device companies, hospitals, academic institutions, cardiovascular societies, and technology developers are accelerating product innovation, clinical research, physician education, and commercialization across the intravascular imaging ecosystem.

Segment Analysis

The report provides an extensive analysis of the intravascular imaging market across technology, product, application, end user, and geography, enabling stakeholders to identify high-growth segments and emerging investment opportunities.

Based on technology, the market is analyzed across intravascular ultrasound (IVUS), optical coherence tomography (OCT), near-infrared spectroscopy (NIRS), and multi-modality imaging.

Intravascular ultrasound (IVUS) accounts for the largest share of the market owing to its widespread clinical adoption, extensive evidence base, and ability to accurately assess vessel dimensions, plaque burden, lumen size, and stent expansion during coronary and peripheral interventions. IVUS is increasingly utilized to optimize percutaneous coronary interventions (PCI), improve procedural precision, reduce restenosis, and support treatment of complex coronary lesions.

Optical coherence tomography (OCT) is expected to witness the fastest growth during the forecast period due to its ultra-high-resolution imaging capability, enabling detailed visualization of vessel microstructures, plaque morphology, stent strut apposition, tissue coverage, and procedural outcomes. Growing physician preference for OCT-guided PCI and continuous technological advancements are accelerating market adoption.

Near-infrared spectroscopy (NIRS) continues to gain traction owing to its ability to identify lipid-rich plaques and assess plaque composition, thereby supporting cardiovascular risk assessment and treatment planning. Multi-modality imaging platforms that integrate IVUS, OCT, and NIRS are also expected to experience significant growth as clinicians increasingly seek comprehensive structural and compositional vascular assessment within a single procedure.

Based on product, the market is segmented into catheters, consoles, and software.

Catheters represent the largest product segment owing to their recurring utilization during every intravascular imaging procedure. Increasing procedural volumes, technological advancements in catheter design, improved flexibility, enhanced imaging quality, and compatibility with advanced imaging consoles continue to drive demand.

Consoles are witnessing steady growth due to increasing installation of next-generation imaging platforms equipped with artificial intelligence, automated vessel analysis, high-speed image processing, and integrated procedural guidance capabilities. Modern consoles improve workflow efficiency and support more accurate clinical decision-making.

Software is expected to register robust growth owing to increasing implementation of artificial intelligence-powered image analysis, automated lumen segmentation, plaque characterization, quantitative vascular analysis, procedural planning, and cloud-based image management solutions. Advanced software platforms improve diagnostic accuracy while reducing operator variability and interpretation time.

Based on application, the market is evaluated across coronary interventions and peripheral interventions.

Coronary interventions account for the largest share of the market owing to the increasing prevalence of coronary artery disease (CAD), growing volumes of percutaneous coronary intervention (PCI), and expanding clinical evidence supporting intravascular imaging-guided stent implantation. Intravascular imaging enables accurate lesion characterization, optimal stent sizing, appropriate stent expansion, and improved long-term cardiovascular outcomes.

Peripheral interventions are expected to witness significant growth during the forecast period due to increasing prevalence of peripheral artery disease (PAD), rising adoption of minimally invasive vascular procedures, and expanding use of intravascular imaging in lower extremity, carotid, and other peripheral vascular interventions. Advanced imaging supports lesion assessment, vessel sizing, plaque characterization, and optimization of endovascular procedures.

Based on end user, the market is segmented into hospitals, cardiac catheterization laboratories, ambulatory surgical centers, and other end users.

Hospitals continue to account for the largest market share owing to the availability of advanced cardiovascular departments, experienced interventional cardiologists, comprehensive catheterization laboratory infrastructure, and increasing adoption of image-guided interventions. Large tertiary hospitals continue to invest in advanced intravascular imaging technologies to improve procedural outcomes and expand complex cardiovascular intervention capabilities.

Cardiac catheterization laboratories are expected to witness substantial growth due to increasing procedure volumes, growing implementation of advanced imaging systems, and expanding adoption of AI-assisted procedural guidance. Ambulatory surgical centers (ASCs) are also gradually increasing utilization of intravascular imaging technologies as minimally invasive cardiovascular procedures continue to shift toward outpatient settings.

Regional Analysis

The report offers a comprehensive assessment of market performance across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Each regional analysis considers cardiovascular disease burden, healthcare infrastructure, catheterization laboratory capacity, reimbursement environment, regulatory landscape, physician adoption, and competitive intensity to provide a holistic understanding of regional growth dynamics.

North America currently represents the largest share of the global intravascular imaging market owing to its advanced cardiovascular healthcare infrastructure, high adoption of image-guided interventions, favorable reimbursement environment, increasing prevalence of coronary artery disease, and strong presence of leading medical device manufacturers. Growing physician awareness, expanding clinical evidence, and continuous technological innovation continue to strengthen regional market leadership.

Europe demonstrates strong market growth supported by increasing adoption of intravascular imaging-guided PCI, expanding clinical guideline recommendations, growing investments in catheterization laboratory modernization, and rising demand for precision cardiovascular care. Continuous research activities and favorable healthcare policies are further supporting regional adoption.

Asia-Pacific is expected to register the fastest growth during the forecast period due to rapidly increasing cardiovascular disease prevalence, expanding healthcare infrastructure, growing volumes of coronary interventions, rising healthcare expenditure, and increasing investments in advanced cardiovascular imaging technologies across China, Japan, India, South Korea, Australia, and Southeast Asian countries. Improving physician training and increasing availability of advanced catheterization laboratories continue to create substantial market opportunities.

Latin America and the Middle East & Africa are also expected to present attractive growth opportunities as healthcare systems continue to modernize, cardiovascular disease awareness increases, and access to advanced interventional cardiology technologies expands. Rising investments in cardiovascular care, improving healthcare infrastructure, and growing adoption of minimally invasive procedures are expected to support market growth across these emerging regions.

Competitive Landscape

The report presents a detailed evaluation of the competitive landscape, offering valuable insights into the strategic positioning of major industry participants. It examines company portfolios, business strategies, technological capabilities, product launches, regulatory approvals, mergers and acquisitions, partnerships, collaborations, geographic expansion initiatives, research and development investments, and other significant corporate developments shaping the competitive environment.

Company benchmarking enables stakeholders to compare market participants based on their intravascular imaging technology portfolios, imaging catheter offerings, console platforms, software capabilities, artificial intelligence expertise, clinical evidence, geographic presence, innovation pipelines, and competitive strengths. The report also evaluates the evolving competitive intensity resulting from continuous advancements in intravascular ultrasound (IVUS), optical coherence tomography (OCT), near-infrared spectroscopy (NIRS), hybrid imaging technologies, artificial intelligence, machine learning, computational image analysis, cloud-based data management, and image-guided cardiovascular interventions, along with increasing investments in precision interventional cardiology.

As healthcare providers increasingly prioritize precision-guided cardiovascular interventions, minimally invasive procedures, and improved long-term patient outcomes, market participants are focusing on developing integrated intravascular imaging ecosystems that combine advanced imaging catheters, AI-powered image analysis, automated vessel sizing, plaque characterization, procedural guidance software, cloud-enabled workflow management, and next-generation imaging consoles. These technologies enable physicians to optimize lesion assessment, improve stent selection and deployment, reduce procedural complications, and enhance clinical decision-making during coronary and peripheral vascular interventions.

Continuous innovation aimed at improving imaging resolution, catheter flexibility, procedural efficiency, artificial intelligence-assisted interpretation, workflow integration, interoperability, cybersecurity, scalability, and integration with cardiovascular information systems (CVIS), catheterization laboratory platforms, hospital information systems (HIS), electronic health records (EHRs), and hemodynamic monitoring systems is expected to strengthen competitive differentiation across the market. Leading companies are also strengthening their global market presence through strategic collaborations with hospitals, cardiovascular centers, academic institutions, physician societies, and research organizations while investing in product innovation, clinical trials, physician education, regulatory approvals, and geographic expansion.

Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., Terumo Corporation, Infraredx, Inc. (Nipro Corporation), ACIST Medical Systems, Inc. (Bracco Imaging S.p.A.), Conavi Medical Corp., Siemens Healthineers AG, Canon Medical Systems Corporation, and Shenzhen Heartcare Medical Technology Co., Ltd.

How This Report Helps

  • Provides reliable market size estimates and long-term growth forecasts.
  • Evaluates major market drivers, restraints, opportunities, challenges, and emerging industry trends.
  • Identifies high-growth technology, product, application, end-user, and regional segments.
  • Assesses evolving technology adoption and innovation across the intravascular imaging ecosystem.
  • Benchmarks leading companies based on their product portfolios, strategic initiatives, technological capabilities, clinical evidence, and competitive positioning.
  • Supports business expansion, investment planning, partnership evaluation, cardiovascular imaging adoption, catheterization laboratory modernization, and product development initiatives.
  • Delivers actionable insights for medical device manufacturers, hospitals, cardiovascular centers, interventional cardiologists, investors, consultants, and other industry stakeholders.

Key Questions Answered

  • What is the current size of the global intravascular imaging market, and what is its projected growth through 2036?
  • Which factors are driving, restraining, and influencing market growth?
  • What opportunities and challenges are expected to shape the industry during the forecast period?
  • Which technology, product, application, end-user, and regional segments are expected to witness the strongest growth?
  • Which regions are expected to offer the most attractive business opportunities?
  • Who are the leading companies operating in the market, and how are they strengthening their competitive positions?
  • What recent technological developments, product launches, regulatory approvals, partnerships, mergers and acquisitions, and strategic initiatives are influencing the competitive landscape?
  • How can stakeholders leverage market intelligence from this report to support strategic planning, investment decisions, image-guided cardiovascular interventions, catheterization laboratory optimization, and next-generation intravascular imaging product development?

TABLE OF CONTENTS

1. Market Definition & Scope

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency Considered
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Assumptions for the Study

3. Executive Summary

  • 3.1. Overview
  • 3.2. Segmental Analysis
    • 3.2.1. Market Analysis, by Technology
    • 3.2.2. Market Analysis, by Product Component
    • 3.2.3. Market Analysis, by Application
    • 3.2.4. Market Analysis, by End User
    • 3.2.5. Market Analysis, by Geography
  • 3.3. Competitive Analysis

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Drivers
      • 4.2.1.1. Growing Volume of Complex PCIs and Calcified Lesions
      • 4.2.1.2. Strong Clinical Evidence Supporting Imaging-Guided PCI (Stats: 38% TVF Reduction)
      • 4.2.1.3. Integration of AI-Powered Automated Vessel Analysis Tools
    • 4.2.2. Restraints
      • 4.2.2.1. High Procedural Costs and Reimbursement Disparities
      • 4.2.2.2. Technical Learning Curve and Procedural Efficiency Concerns
    • 4.2.3. Opportunities
      • 4.2.3.1. Expansion into Peripheral Vascular Interventions for PAD
      • 4.2.3.2. Development of Cloud-Based Tele-proctoring and Remote Assistance
    • 4.2.4. Challenges
      • 4.2.4.1. Managing Cybersecurity and Data Privacy in Connected Consoles
      • 4.2.4.2. Competition Between IVUS and OCT Modalities
    • 4.2.5. Trends
      • 4.2.5.1. Shift Toward Software-Defined, Multi-Modality Imaging Platforms
      • 4.2.5.2. Rise of Real-Time AI-Guided Procedural Optimization
  • 4.3. Porter's Five Forces Analysis
  • 4.4. Regulatory Landscape
  • 4.5. Value Chain Analysis

5. Global Intravascular Imaging Market, by Technology

  • 5.1. Overview
  • 5.2. Intravascular Ultrasound (IVUS)
    • 5.2.1. Rotational IVUS
    • 5.2.2. Solid-State (Phased-Array) IVUS
  • 5.3. Optical Coherence Tomography (OCT)
  • 5.4. Near-Infrared Spectroscopy (NIRS)
  • 5.5. Multi-Modality Imaging Systems

6. Global Intravascular Imaging Market, by Product Component

  • 6.1. Overview
  • 6.2. Imaging Catheters (Disposables)
    • 6.2.1. Coronary Catheters
    • 6.2.2. Peripheral Catheters
  • 6.3. Imaging Consoles & Hardware
  • 6.4. Software & AI Modules

7. Global Intravascular Imaging Market, by Application

  • 7.1. Overview
  • 7.2. Coronary Interventions
    • 7.2.1. Complex PCI & CTO
    • 7.2.2. Left Main Intervention
  • 7.3. Peripheral Interventions
    • 7.3.1. Carotid Imaging
    • 7.3.2. Iliofemoral & Popliteal Imaging

8. Global Intravascular Imaging Market, by End User

  • 8.1. Overview
  • 8.2. Hospitals & Cardiac Catheterization Labs
  • 8.3. Ambulatory Surgical Centers (ASCs)
  • 8.4. Academic & Research Institutes

9. Global Intravascular Imaging Market, by Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S. (Stats: ~40% Global Market Share)
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. Japan (Stats: >80% PCI Imaging Adoption)
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Australia
    • 9.4.5. Rest of Asia-Pacific
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America
  • 9.6. Middle East & Africa

10. Competitive Landscape

  • 10.1. Overview
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Dashboard
  • 10.4. Vendor Market Positioning
  • 10.5. Market Share Analysis, 2025

11. Company Profiles

  • 11.1. Abbott Laboratories
  • 11.2. Boston Scientific Corporation
  • 11.3. Royal Philips (Philips Healthcare)
  • 11.4. Terumo Corporation
  • 11.5. Infraredx, Inc. (Nipro Corporation)
  • 11.6. ACIST Medical Systems (Bracco Group)
  • 11.7. Conavi Medical Inc.
  • 11.8. Gentuity, LLC
  • 11.9. Axle International
  • 11.10. Insight Guided Systems
  • 11.11. Avinger, Inc.
  • 11.12. Silicon Valley Medical Instruments
  • 11.13. Pulse Medical Imaging Technology (Shanghai) Co., Ltd.
  • 11.14. Lepu Medical Technology (Beijing) Co., Ltd.
  • 11.15. MicroPort Scientific Corporation
  • 11.16. APT Medical Inc.

12. Appendix